PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS

Abstract: pharmacoeconomic study of treatment primary open-angle glaucoma with fix combination of carbonic anhydrise inhibitors and betablockers by mean of cost-utility, willingness-to-pay, cost minimization and budget impact analysis was conducted. Results have shown, that Azarga has benefits compa...

Descripció completa

Dades bibliogràfiques

Autor principal:	M. V. Protsenko
Format:	Artigo
Idioma:	Russo
Publicat:	IRBIS LLC 2015-03-01
Col·lecció:	Фармакоэкономика
Matèries:	primary open-angle glaucoma pharmacoeconomic studies cost-utility analysis willingness-to-pay analysis cost minimization analysis budget impact analysis timolol brinzolamid
Accés en línia:	https://www.pharmacoeconomics.ru/jour/article/view/38
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!